Acucela Inc Now Known As Kubota Vision Inc Is A Clinical Stage Biotechnology Company Based In Seattlewashingtonfounded In April 2002 By Drryo Kubotathe Company Focuses On Developing Innovative Treatments For Degenerative Eye Diseasesit Specializes In Drugs Utilizing Its Proprietary Visual Cycle Modulationvcmtechnologywhich Aims To Treat Conditions Like Age Related Macular Degenerationamdthrough Oral Medicationsproviding A Less Invasive Alternative To Traditional Treatments One Of Its Key Product Candidates Is Emixustat Hydrochloridedeveloped For Geographic Atrophy Secondary To Dry Amdthis Candidate Has Undergone Clinical Trials And Received Fda Fast Track Designationkubota Vision Has Established Significant Partnershipsincluding A Co Development Agreement With Otsuka Pharmaceutical Co Ltdthe Company Rebranded In August 2020 To Reflect Its Integration Into Kubota Pharmaceutical Holdings Co Ltd Emphasizing Its Commitment To Advancing Vision Care Technologies
